Expert Chaslau Koniukh
  • Companies
  • Global investment
  • Investors
  • Terminology
  • Economy
  • Stock Market
  • World exchanges
  • Tech and Marketing
Merck
Stock Market

Merck announced a deal with Imago

04.02.2023
2 min read

Merck plans to expand its range of drugs for blood diseases

German company Merck announced the acquisition of Imago, a pharmaceutical company that produces cancer drugs. According to the deal, the buyer will pay $36 per share in cash. Such an amount is a premium of almost 107% compared with the data of the last auction.
The decision to buy Imago depends on the fact that Merck will expire in 2028 for patents on cancer drugs developed by Keytruda. And the company plans to expand its list of drugs for blood diseases. As part of that, Merck bought Acceleron Pharma last year for more than $11 billion. Thus, the German manufacturer added an experimental drug for lowering blood pressure to its list of drugs.
According to BMO Capital Markets, the Imago acquisition will not be enough for Merck to make up for the loss of patents from Keytruda. Therefore, the manufacturer is likely to go for the purchase of other companies, which will give an opportunity to expand the portfolio and increase business income.
Imago is of interest to Merck primarily for its drug, which is claimed to fight various types of blood cancers. The drug is now undergoing testing and interim studies. So far, the parties have not disclosed detailed information about the deal and its terms, we only know that it should be closed by the end of the current quarter.Merck pharmaceutical and biologics companyMerck is considered the world’s oldest pharmaceutical and biologics company. It emerged in 1668 from a small pharmacy in Darmstadt, Germany, run by Jacob Merck. Gradually the business expanded, more and more pharmacies opened and by 1820 the company already had representative offices in a number of European cities. In 1827 the first chemical-pharmaceutical enterprise appeared on the basis of a pharmacy and it was here that morphine was commercially produced for the first time. In 1884 cocaine was added to the assortment. Nine years later, a new line appeared in the company – bacteriology, which was engaged in the production of vaccines against widespread diseases of that time – tuberculosis, smallpox, and typhus. In addition, Merck produced serums against diphtheria, streptococci, and pneumococci.
In 1891, a subsidiary of Merck was founded in the United States, and a few years later the first pharmaceutical factory started operating.
One of the models of the company’s development today is the process of mergers and acquisitions. For example, in 2006 Swiss Serona, which is active in the field of biotechnology, joined the structure of the business. In 2010, Merck bought the American manufacturer of reagents and equipment for laboratories Millipore, and in 2015 – Sigma-Aldrich, which produces reagents. Despite its long history, Merck remains a family business run by the eleventh generation of Merck. Family members are not allowed to sell their shares to outside investors.

Tags: Stock Market
0
Previous Post Germany and other countries recorded a slowdown in inflation Next Post Alexa voice assistant forces Amazon to go to extremes

You Might Also Like

US-China trade negotiations
Stock Market
US-China trade negotiations: expert hopes and forecasts
11.08.2020
cheap Russian shares
Stock Market
Cheap Russian shares are actively bought at Moscow Stock Exchange
09.12.2020
Xpeng Motors
Stock Market
Chinese company Xpeng Motors placed its shares on the New York Stock Exchange
28.04.2021
The European Union created a fund
Stock Market
The European Union created a fund of 5 billion euros to help businesses
13.05.2022
record inequality in the U.S.
Stock Market
Record inequality in the U.S.: the reasons for the wealthy’s capital increase
10.07.2022
default of Chinese companies
Stock Market
Record defaults by Chinese companies recorded
19.08.2022

Recent Posts

  • 1Erik Penser
    Erik Penser: the ups and downs of the Swedish businessman
    30.03.2023
  • 2Royal Dutch Shell logo
    Royal Dutch Shell: the history of the British-Dutch company
    29.03.2023
  • 3discount window features
    Discount window: peculiarities of lending from the Federal Reserve System
    28.03.2023
  • 4LG Energy Solution
    LG Energy Solution invests in battery production expansion
    27.03.2023
  • 5troubled crypto exchanges-2
    SEC to closely monitor troubled crypto exchanges
    26.03.2023

Popular Posts

  • Skolkovo analysts: the Russian energy market is suffering losses
  • Businessman Chuck Feeney: the man who gave the world Duty Free
  • Field of activity of the American Monsanto Company Corporation
  • Is the oil market waiting for another collapse of quotations: the opinion of a LUKOIL analyst?

Social media

Editor's Picks

Chaslau Koniukh
Analytics

American bankers from JPMorgan and Goldman Sachs advise to invest in gold: review by Chaslau Koniukh.

Press Secretary
17.08.2020
Expert Chaslau Koniukh
Analytics

Chaslau Koniukh on the analysts’ opinion on the key stake size change soon

Press Secretary
18.06.2020
expert Chaslau Koniukh
Analytics

Chaslau Koniukh: Internet trade market in Russia may reach 2.78 trillion rubles.

Press Secretary
30.05.2020
Will the U.S. oil shale industry be able to quickly recover from the crisis: A Review by Chaslau Koniukh
Analytics

Will the U.S. oil shale industry be able to quickly recover from the crisis: A Review by Chaslau Koniukh

Press Secretary
16.05.2020

Latest Posts

Japanese Central Bank
Japan’s Central Bank widened the range of bond yields
31.03.2023
Erik Penser
Erik Penser: the ups and downs of the Swedish businessman
30.03.2023
Royal Dutch Shell logo
Royal Dutch Shell: the history of the British-Dutch company
29.03.2023

Chaslau Koniukh

Expert Chaslau Koniukh

Chaslau Koniukh – an expert in marketing and project management, IT consulting, international investments, investor, financial analyst. A commodity trader, private consultant, entrepreneur, lecturer, author of several articles on the stock market.

Popular Posts

  • Skolkovo analysts: the Russian energy market is suffering losses
  • Businessman Chuck Feeney: the man who gave the world Duty Free
  • Field of activity of the American Monsanto Company Corporation
  • Is the oil market waiting for another collapse of quotations: the opinion of a LUKOIL analyst?
  • US economic growth rate: forecast for the coming year
Expert Chaslau Koniukh
  • Facebook
  • Twitter
  • Instagram
  • Biography

Chaslau Koniukh – an expert in marketing and project management, international investments, financial analyst.

Social media

Menu

  • Biography
  • Companies and corporations
  • Global investment
  • Investors and Entrepreneurs
  • Economy
  • Market terminology
  • Stock Market
  • World exchanges
  • Tech and Marketing
  • Analytics